The Concord Biotech IPO subscription status has started on August 04, 2023, and it is also being subscribed by QIB, NII, and RII. The Concord Biotech IPO began on August 04, 2023 and will end on August 08, 2023. It will be fully subscribed by August 08, 2023. Concord Biotech IPO is preparing to raise ₹1551.00 crores through its fresh issue and offer for sale, in which the fresh issue is ₹0 crores and the offer for sale is ₹1551.00 crores, and the Concord Biotech IPO price band is fixed ₹705 to ₹741 per share. Check out Concord Biotech IPO GMP here.
Concord Biotech Limited is a leading vertically integrated, R&D driven biotechnological powerhouse that manufactures Active Pharmaceutical Ingredients through fermentation & semi-synthetic process and Finished formulations. Concord Biotech Limited is a India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in market share.
Concord Biotech IPO reserved shares in this IPO, 50% for QIB and 15% for NII, and 35% for the retail category have been reserved. To know the Concord Biotech IPO Subscription Status, you can see the below-day Subscription. You can check Concord Biotech IPO Allotment Status here.
Concord Biotech IPO Review :
| Details | Valuation |
| PAT 2023 : Issue Price : EPS 2023 : PE Ratio : ROE : RoNW : ROCE : Debt/Equity : NAV Value : Total Assets : Market Cap : Pre Holding : Post Holding : | ₹240.08 Cr ₹741/ EQ 22.95 32.28x 20.06 % 20.06 % 18.91 % 0.02 ₹123.31 ₹1513.98 Cr ₹7752.06 Cr 97.38% 77.38% |
| Team Review : | ✔ Apply For Long Term & Listing Gain |
Concord Biotech IPO Subscription Status {Live Update} :
The total Concord Biotech IPO Subscription Status subscribed 24.86x times so far, with QIB subscribed 67.67x and NII subscribed 16.99x times & RII 3.78x times and EMP 24.47x times on Day 3. {Update Time : 08 Aug 2023 05:00 Pm}
| Category | Day 1 | Day 2 | Day 3 |
| QIB : | 0.01x | 1.61x | 67.67x |
| NII : _________ bNII (above ₹10L): sNII (below ₹10L): | 1.01x ______ 0.96x 1.11x | 5.22x ______ 5.12x 5.42x | 16.99x ______ 19.30x 12.37x |
| RII : | 0.72x | 2.26x | 3.78x |
| EMP : | 5.73x | 15.68x | 24.47x |
| Total : | 0.58x | 2.72x | 24.86x |
Concord Biotech IPO Net Shares Offered:
Concord Biotech IPO is a public issue of 1,46,50,957 equity shares. The issue offers 41,83,130 shares to qualified institutional buyers, 31,37,348 shares to non-institutional investors, and 73,20,479 shares to retail investors.
| Category | Net EQ Offer | Amount(in Cr) |
| Anchor : | 62,74,695 | 464.95 Cr |
| QIB : | 41,83,130 | 309.96 Cr |
| NII : ________________________ bNII (bids above ₹10L) : sNII (bids below ₹10L) : | 31,37,348 ______________ 20,91,565 10,45,783 | 232.47 Cr _______ 154.98 Cr 77.49 Cr |
| RII : | 73,20,479 | 542.45 Cr |
| EMP : | 10,000 | 0.67 Cr |
| Total : | 1,46,50,957 | ₹1551.00 Cr |
Investor Categories Define :
■ Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds, insurance companies, and pension schemes.
■ Non-Institutional Investors(NII): Retail Individual Investors, NRIs, Companies, Trusts, etc
● sNII (bids below Rs 10L): The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category.
● bNII (bids above Rs 10L): The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory.
■ Retail Individual Investors (RII): Retail Individual Investors or NRIs
■ Employee (EMP): Eligible Employees
■ Others: Eligible Shareholders
Concord Biotech IPO Subscription Status FAQs :
How much was the total Concord Biotech IPO Subscription Status?
The total Concord Biotech IPO Subscription Status 24.86x times Day 3.
What is the Concord Biotech IPO retail subscription Status?
Concord Biotech IPO Retail Subscription 3.76x times Day 3.
How much is the Concord Biotech IPO QIB subscription Status?
The Concord Biotech IPO QIB subscription 67.67x times Day 3.
How much did Concord Biotech IPO NII subscribe?
Concord Biotech IPO NII Subscription 16.99x times Day 3.
What is Concord Biotech IPO Investors Portion?
The investors’ portion for QIB 50%, NII 15%, RII 35%.
What is Concord Biotech IPO Allotment Date?
Concord Biotech IPO allotment date is 11 August 2023.
What is Concord Biotech IPO Listing Date?
Concord Biotech IPO listing date is 18 August 2023. The IPO to list on NSE, BSE.
How to Apply the Concord Biotech IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Upstox?
Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Groww?
Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Concord Biotech IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Concord Biotech IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Concord Biotech IPO GMP: Click Here Concord Biotech IPO Details: Click Here Concord Biotech IPO Allotment: Click Here Concord Biotech IPO Listing: Click Here |
All Concord Biotech IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.